Publications by authors named "Tim D Holmes"

Claim this Profile
A
Author Correction: NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development.
Vedrana Jelenčić, Marko Šestan, Inga Kavazović, Maja Lenartić, Sonja Marinović, Tim D Holmes

Nat Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herring roe oil in treatment of psoriasis - influence on immune cells and cytokine network.
Aleksandra Petrovic, Ingvild Bueide, Kåre Steinar Tveit, Hogne Hallaråker, Bodil Bjørndal, Tim D Holmes

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8 T cells.
Eric Y Helm, Tomas Zelenka, Valeriu B Cismasiu, Shamima Islam, Leonardo Silvane, Tim D Holmes

Sci Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic virus treatment differentially affects the CD56 and CD56 NK cell subsets in vivo and regulates a spectrum of human NK cell activity.
Michelle Wantoch, Erica B Wilson, Alastair P Droop, Sarah L Phillips, Matt Coffey, Tim D Holmes

Immunology· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.
Tim D Holmes, Ram Vinay Pandey, Eric Y Helm, Heinrich Schlums, Hongya Han

Sci Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development.
Vedrana Jelenčić, Marko Šestan, Inga Kavazović, Maja Lenartić, Sonja Marinović, Tim D Holmes

Nat Immunol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-function mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.
Bianca Tesi, Josef Davidsson, Matthias Voss, Elisa Rahikkala, Tim D Holmes

Blood· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive NK cells can persist in patients with mutation depleted of stem and progenitor cells.
Heinrich Schlums, Moonjung Jung, Hongya Han, Jakob Theorell, Venetia Bigley, Tim D Holmes

Blood· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell memory in context.
Tim D Holmes, Yenan T Bryceson

Semin Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homozygous STIM1 mutation impairs store-operated calcium entry and natural killer cell effector function without clinical immunodeficiency.
David A Parry, Tim D Holmes, Nikita Gamper, Walid El-Sayed, Nishani T Hettiarachchi

J Allergy Clin Immunol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.
Heinrich Schlums, Frank Cichocki, Bianca Tesi, Jakob Theorell, Vivien Beziat, Tim D Holmes

Immunity· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT.
Tim D Holmes, Erica B Wilson, Emma V I Black, Andrew V Benest, Candida Vaz

Proc Natl Acad Sci U S A· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human NK cell activation/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cells.
Tim D Holmes, Yasser M El-Sherbiny, Adam Davison, Sally L Clough, G Eric Blair

J Immunol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic activation of the cytotoxic phenotype during human NK cell development.
Josephine L Meade, Erica B Wilson, Tim D Holmes, Erika A de Wynter, Peter Brett

J Immunol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
Yasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, Dennis McGonagle, Sarah L Mackie

Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis